Rettie AE - Search Results

1

Effect of VKORC1 haplotypes on transcriptional regulation and warfarin dose.

Rieder MJ, Reiner AP, Gage BF, Nickerson DA, Eby CS, McLeod HL, Blough DK, Thummel KE, Veenstra DL, Rettie AE. Rieder MJ, et al. Among authors: rettie ae. N Engl J Med. 2005 Jun 2;352(22):2285-93. doi: 10.1056/NEJMoa044503. N Engl J Med. 2005. PMID: 15930419 Free article.

2

Purification of macaque liver flavin-containing monooxygenase: a form of the enzyme related immunochemically to an isozyme expressed selectively in adult human liver.

Sadeque AJ, Thummel KE, Rettie AE. Sadeque AJ, et al. Among authors: rettie ae. Biochim Biophys Acta. 1993 Mar 5;1162(1-2):127-34. doi: 10.1016/0167-4838(93)90138-h. Biochim Biophys Acta. 1993. PMID: 8448176

3

Immunoquantitation of FMO1 in human liver, kidney, and intestine.

Yeung CK, Lang DH, Thummel KE, Rettie AE. Yeung CK, et al. Among authors: rettie ae. Drug Metab Dispos. 2000 Sep;28(9):1107-11. Drug Metab Dispos. 2000. PMID: 10950857

4

Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen.

Dong H, Haining RL, Thummel KE, Rettie AE, Nelson SD. Dong H, et al. Among authors: rettie ae. Drug Metab Dispos. 2000 Dec;28(12):1397-400. Drug Metab Dispos. 2000. PMID: 11095574

5

Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy.

Higashi MK, Veenstra DL, Kondo LM, Wittkowsky AK, Srinouanprachanh SL, Farin FM, Rettie AE. Higashi MK, et al. Among authors: rettie ae. JAMA. 2002 Apr 3;287(13):1690-8. doi: 10.1001/jama.287.13.1690. JAMA. 2002. PMID: 11926893

6

CYP2C9 exon 4 mutations and warfarin dose phenotype in Asians.

Rettie AE, Tai G, Veenstra DL, Farin FM, Srinouanprachan S, Lin YS, Thummel KE, Hines RN. Rettie AE, et al. Blood. 2003 Apr 1;101(7):2896-7. doi: 10.1182/blood-2002-11-3452. Blood. 2003. PMID: 12642346 Free article. No abstract available.

7

CYP2C9 haplotype structure in European American warfarin patients and association with clinical outcomes.

Veenstra DL, Blough DK, Higashi MK, Farin FM, Srinouanprachan S, Rieder MJ, Rettie AE. Veenstra DL, et al. Among authors: rettie ae. Clin Pharmacol Ther. 2005 May;77(5):353-64. doi: 10.1016/j.clpt.2005.01.019. Clin Pharmacol Ther. 2005. PMID: 15900281

8

In-vitro and in-vivo effects of the CYP2C9*11 polymorphism on warfarin metabolism and dose.

Tai G, Farin F, Rieder MJ, Dreisbach AW, Veenstra DL, Verlinde CL, Rettie AE. Tai G, et al. Among authors: rettie ae. Pharmacogenet Genomics. 2005 Jul;15(7):475-81. doi: 10.1097/01.fpc.0000162005.80857.98. Pharmacogenet Genomics. 2005. PMID: 15970795

9

Association of Vitamin K epoxide reductase complex 1 (VKORC1) variants with warfarin dose in a Hong Kong Chinese patient population.

Veenstra DL, You JH, Rieder MJ, Farin FM, Wilkerson HW, Blough DK, Cheng G, Rettie AE. Veenstra DL, et al. Among authors: rettie ae. Pharmacogenet Genomics. 2005 Oct;15(10):687-91. doi: 10.1097/01.fpc.0000174789.77614.68. Pharmacogenet Genomics. 2005. PMID: 16141794

10

A case study of acenocoumarol sensitivity and genotype-phenotype discordancy explained by combinations of polymorphisms in VKORC1 and CYP2C9.

Rettie AE, Farin FM, Beri NG, Srinouanprachanh SL, Rieder MJ, Thijssen HH. Rettie AE, et al. Br J Clin Pharmacol. 2006 Nov;62(5):617-20. doi: 10.1111/j.1365-2125.2006.02688.x. Epub 2006 Jul 21. Br J Clin Pharmacol. 2006. PMID: 16869821 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters